26 March, 2025 | Wednesday
BioPharma Boardroom
Granular Therapeutics speeds up development of mast cell disease pipeline.

Dermatology industry veteran Thibaud Portal, PhD appointed as CEO  Granular Therapeutics, (Granular) a private biotech company specialising in p...

March 30, 2023 | Thursday | News
Pharmaron's Liverpool Gene Therapy CDMO begins expansion after receiving UK government grant for £151m investment.

This major expansion project will provide a four-fold increase in gene therapy process development and analytical capacity accommodating viral vector, DNA ...

March 29, 2023 | Wednesday | News
Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs

Curia, a leading contract research, development and manufacturing organization, today announced a collaboration with Corning Incorporated to expand and acc...

March 26, 2023 | Sunday | News

Partner Content

BioPharma BreakThrough's

Editor Picks

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
  View poll results   More polls
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
BioPharma Boardroom

About Us Media Pack Contact Us Privacy Policy

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close